Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Nature

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Bone Marrow Transplantation (30)
Leukemia (16)
British Journal of Cancer (10)
Oncogene (4)
The Pharmacogenomics Journal (3)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (52)
Special Features (7)
Amendments and Corrections (5)
Correspondence (5)
Reviews (2)

Subject Check one or more subjects to show results from those subjects only.

Biochemistry
Biological techniques
Biomarkers
Cancer
Cell biology
Chemical biology
Computational biology and bioinformatics
Diseases
Drug discovery
Genetics
Health care
Immunology
Medical research
Microbiology
Molecular biology
Oncology
Risk factors
Stem cells

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–50 of 71 results

Advanced filters: Author: C Greil Clear advanced filters

Patritumab deruxtecan in leptomeningeal metastatic disease of solid tumors: the phase 2 TUXEDO-3 trial

As presented at the 2025 ASCO Annual Meeting: in cohort 3 of the phase 2 TUXEDO-3 trial, patients with leptomeningeal metastatic disease from any solid tumor were treated with the HER3-targeting antibody–drug conjugate patritumab deruxtecan and showed encouraging 3-month overall survival rates.

Matthias Preusser
Javier Garde-Noguera
Rupert Bartsch
ResearchOpen Access30 May 2025
Nature Medicine

Volume: 31, P: 2797-2805
C to U RNA editing of MFN1 is regulated by ADARB1 and associates with favourable prognosis in chronic lymphocytic leukemia

Alejandra Gonzalez Martinez
Franz Josef Gassner
Roland Geisberger
ResearchOpen Access14 Aug 2025
Scientific Reports

Volume: 15, P: 1-13
Maintenance Efficacy of Divalproex in the Prevention of Bipolar Depression

Laszlo Gyulai
Charles L Bowden
Patricia J Wozniak
Research12 Mar 2003
Neuropsychopharmacology

Volume: 28, P: 1374-1382
sST2 is a key outcome biomarker in COVID-19: insights from discovery randomized trial

David M. Smadja
Clément R. Massonnaud
Benjamin Leveau
ResearchOpen Access24 Apr 2025
Scientific Reports

Volume: 15, P: 1-16
Poly-ligand profiling differentiates trastuzumab-treated breast cancer patients according to their outcomes

Patients’ selection is particularly important in cancer treatment. Here the authors present a proof-of-principle methodology that could be potentially important in assisting therapeutic decisions in the treatment of breast cancer patients.

Valeriy Domenyuk
Zoran Gatalica
David Spetzler
ResearchOpen Access23 Mar 2018
Nature Communications

Volume: 9, P: 1-9
Evaluation of EuroFlow minimal residual disease measurement and donor chimerism monitoring following tandem auto-allogeneic transplantation for multiple myeloma

Joanne L. C. Tan
Tongted Das
Andrew Spencer
Research01 Dec 2020
Bone Marrow Transplantation

Volume: 56, P: 1116-1125
A new fingerprint method for sequence analysis of chromosomal translocations at the genomic DNA level

T Leis
R Repp
F Lampert
Research29 May 1998
Leukemia

Volume: 12, P: 758-763
Favorable immune recovery and low rate of GvHD in children transplanted with partially T cell-depleted PBSC grafts

Christian Martin Seitz
Matthias Eyrich
Peter Lang
Research24 May 2018
Bone Marrow Transplantation

Volume: 54, P: 53-62
Does chemotherapy-induced neutropaenia result in a postponement of adjuvant or neoadjuvant regimens in breast cancer patients? Results of a retrospective analysis

M Debled
N Houédé
Louis Mauriac
ResearchOpen Access13 Nov 2007
British Journal of Cancer

Volume: 97, P: 1642-1647
Erratum: Defibrotide in the treatment of children with veno-occlusive disease (VOD): a retrospective multicentre study demonstrates therapeutic efficacy upon early intervention

S Corbacioglu
J Greil
A S Schulz
Amendments and Corrections08 Mar 2004
Bone Marrow Transplantation

Volume: 33, P: 673
Correction to: Prognostic factors for survival after allogeneic transplantation in acute lymphoblastic leukemia

C. Greil
M. Engelhardt
R. Wäsch
Amendments and CorrectionsOpen Access08 Jul 2021
Bone Marrow Transplantation

Volume: 56, P: 2042
Current challenges for 3D printing complete dentures: experiences from a multi-centre clinical trial

Cecilie Osnes
Krishan Davda
Andrew Keeling
ResearchOpen Access09 Aug 2023
British Dental Journal

P: 1-7
Quantification of cellular adhesion molecules on malignant B cells from non-Hodgkin’s lymphoma

M-C Jacob
S Agrawal
J Plumas
Research09 Sept 1999
Leukemia

Volume: 13, P: 1428-1433
vestigial suppressor genes and resistance to aminopterin in Drosophila melanogaster

C Bazin
J Silber
Research01 Nov 1992
Heredity

Volume: 69, P: 473-477
The human LASP1 gene is fused to MLL in an acute myeloid leukemia with t(11;17)(q23;q21)

Sabine Strehl
Arndt Borkhardt
Oskar A Haas
Research14 Jan 2003
Oncogene

Volume: 22, P: 157-160
C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large B-cell lymphoma patients

K T Troppan
K Schlick
M Pichler
ResearchOpen Access29 May 2014
British Journal of Cancer

Volume: 111, P: 55-60
Long-term outcome after allogeneic hematopoietic stem cell transplantation for Shwachman–Diamond syndrome: a retrospective analysis and a review of the literature by the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation (SAAWP-EBMT)

Simone Cesaro
Marta Pillon
Carlo Dufour
Research19 Mar 2020
Bone Marrow Transplantation

Volume: 55, P: 1796-1809
Biased distribution of chromosomal breakpoints involving the MLL gene in infants versus children and adults with t(4;11) ALL

Martin Reichel
Esther Gillert
Rolf Marschalek
Research24 May 2001
Oncogene

Volume: 20, P: 2900-2907
Finding a balance in reduced toxicity hematopoietic stem cell transplantation for thalassemia: role of infused CD3+ cell count and immunosuppression

Barbara Meissner
Peter Lang
Rita Beier
ResearchOpen Access07 Feb 2024
Bone Marrow Transplantation

Volume: 59, P: 587-596
The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2− breast cancer patients

P Dubsky
J C Brase
M Filipits
ResearchOpen Access24 Oct 2013
British Journal of Cancer

Volume: 109, P: 2959-2964
Treosulfan vs busulfan conditioning for allogeneic bmt in children with nonmalignant disease: a randomized phase 2 trial

Karl-Walter Sykora
Rita Beier
Krzysztof Kalwak
ResearchOpen Access04 Nov 2023
Bone Marrow Transplantation

Volume: 59, P: 107-116
Development of CLL in the TCL1 transgenic mouse model is associated with severe skewing of the T-cell compartment homologous to human CLL

J Piñón Hofbauer
C Heyder
A Egle
Research24 May 2011
Leukemia

Volume: 25, P: 1452-1458
Establishment and characterization of a human stroma-dependent myeloma cell line (MM5.1) and its stroma-independent variant (MM5.2)

I Van Riet
C De Greef
B Van Camp
Research01 Feb 1997
Leukemia

Volume: 11, P: 284-293
Development and validation of a gene expression-based Breast Cancer Purity Score

Marco Barreca
Matteo Dugo
Maurizio Callari
ResearchOpen Access24 Oct 2024
npj Precision Oncology

Volume: 8, P: 1-11
Fas ligand expression in the bone marrow in myelodysplastic syndromes correlates with FAB subtype and anemia, and predicts survival

P Gupta
GA Niehans
RA Kratzke
Research27 Jan 1999
Leukemia

Volume: 13, P: 44-53
Cytotoxic drugs and the CD95 pathway

C Friesen
S Fulda
K-M Debatin
Reviews03 Nov 1999
Leukemia

Volume: 13, P: 1854-1858
Relationship between clinical and BK virological response in patients with late hemorrhagic cystitis treated with cidofovir: a retrospective study from the European Group for Blood and Marrow Transplantation

S Cesaro
M Pillon
S Santarone
Research10 Dec 2012
Bone Marrow Transplantation

Volume: 48, P: 809-813
Defibrotide in the treatment of children with veno-occlusive disease (VOD): a retrospective multicentre study demonstrates therapeutic efficacy upon early intervention

S Corbacioglu
J Greil
A S Schulz
Research08 Dec 2003
Bone Marrow Transplantation

Volume: 33, P: 189-195
Results of a multicenter phase I/II trial of TCRαβ and CD19-depleted haploidentical hematopoietic stem cell transplantation for adult and pediatric patients

Wolfgang A. Bethge
Matthias Eyrich
Peter Lang
ResearchOpen Access24 Dec 2021
Bone Marrow Transplantation

Volume: 57, P: 423-430
Prognostic factors for survival after allogeneic transplantation in acute lymphoblastic leukemia

C. Greil
M. Engelhardt
R. Wäsch
ResearchOpen Access31 Oct 2020
Bone Marrow Transplantation

Volume: 56, P: 841-852
Incidence of subsequent malignancies after total body irradiation-based allogeneic HSCT in children with ALL – long-term follow-up from the prospective ALL-SCT 2003 trial

Anna Eichinger
Ulrike Poetschger
Michael H. Albert
ResearchOpen Access12 Sept 2022
Leukemia

Volume: 36, P: 2567-2576
Treosulfan–fludarabine–thiotepa-based conditioning treatment before allogeneic hematopoietic stem cell transplantation for pediatric patients with hematological malignancies

Krzysztof Kalwak
Monika Mielcarek
Ajay Vora
ResearchOpen Access20 Mar 2020
Bone Marrow Transplantation

Volume: 55, P: 1996-2007
Allo-SCT using BU, CY and melphalan for children with AML in second CR

R Beier
M H Albert
M G Sauer
Research29 Oct 2012
Bone Marrow Transplantation

Volume: 48, P: 651-656
Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial

Gerald G. Wulf
Bettina Altmann
Lorenz Trümper
Research07 May 2020
Leukemia

Volume: 35, P: 143-155
Effective treatment of steroid and therapy-refractory acute graft-versus-host disease with a novel mesenchymal stromal cell product (MSC-FFM)

Peter Bader
Zyrafete Kuçi
Selim Kuçi
ResearchOpen Access29 Jan 2018
Bone Marrow Transplantation

Volume: 53, P: 852-862
Conventional versus reverse sequence of neoadjuvant epirubicin/cyclophosphamide and docetaxel: sequencing results from ABCSG-34

Rupert Bartsch
Christian F. Singer
Michael Gnant
Research24 Mar 2021
British Journal of Cancer

Volume: 124, P: 1795-1802
Ixazomib–Thalidomide–Dexamethasone for induction therapy followed by Ixazomib maintenance treatment in patients with relapsed/refractory multiple myeloma

Heinz Ludwig
Wolfram Poenisch
Niklas Zojer
ResearchOpen Access27 Sept 2019
British Journal of Cancer

Volume: 121, P: 751-757
Successful SCT for Nijmegen breakage syndrome

M H Albert
A R Gennery
B H Belohradsky
Research17 Aug 2009
Bone Marrow Transplantation

Volume: 45, P: 622-626
Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective

P Bader
H Kreyenberg
J F Beck
Research01 Mar 2004
Bone Marrow Transplantation

Volume: 33, P: 815-821
Efficacy of tamoxifen±aminoglutethimide in normal weight and overweight postmenopausal patients with hormone receptor-positive breast cancer: an analysis of 1509 patients of the ABCSG-06 trial

G Pfeiler
H Stöger
M Gnant
ResearchOpen Access19 Mar 2013
British Journal of Cancer

Volume: 108, P: 1408-1414
The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab

T Magnes
T Melchardt
A Egle
Research18 Jul 2017
The Pharmacogenomics Journal

Volume: 18, P: 474-479
Hematopoietic stem cell transplantation for children with acute myeloid leukemia—results of the AML SCT-BFM 2007 trial

Martin G. Sauer
Peter J. Lang
Arndt Borkhardt
Research02 Oct 2019
Leukemia

Volume: 34, P: 613-624
A DNA damage repair mechanism is involved in the origin of chromosomal translocations t(4;11) in primary leukemic cells

Esther Gillert
Thomas Leis
Rolf Marschalek
Research18 Aug 1999
Oncogene

Volume: 18, P: 4663-4671
Measurable residual disease in chronic lymphocytic leukemia: expert review and consensus recommendations

William G. Wierda
Andrew Rawstron
Peter Hillmen
ReviewsOpen Access24 Jun 2021
Leukemia

Volume: 35, P: 3059-3072
The role of APC/C^Cdh1 in replication stress and origin of genomic instability

C Greil
J Krohs
R Wäsch
Research12 Oct 2015
Oncogene

Volume: 35, P: 3062-3070
Endothelin-1 genetic polymorphism as predictive marker for bevacizumab in metastatic breast cancer

S P Gampenrieder
C Hufnagl
R Greil
Research03 May 2016
The Pharmacogenomics Journal

Volume: 17, P: 344-350
Correction: The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab

T. Magnes
T. Melchardt
A. Egle
Amendments and CorrectionsOpen Access18 Jan 2019
The Pharmacogenomics Journal

Volume: 20, P: 350
Spliced MLL fusions: a novel mechanism to generate functional chimeric MLL-MLLT1 transcripts in t(11;19)(q23;p13.3) leukemia

C Meyer
T Burmeister
R Marschalek
Correspondence25 Jan 2007
Leukemia

Volume: 21, P: 588-590
A prospective comparison of immune reconstitution in pediatric recipients of positively selected CD34⁺ peripheral blood stem cells from unrelated donors vs recipients of unmanipulated bone marrow from related donors

M Eyrich
C Leiler
P G Schlegel
Research05 Aug 2003
Bone Marrow Transplantation

Volume: 32, P: 379-390
Hematopoietic stem cell transplantation for hematological malignancies in Europe

A Gratwohl
H Baldomero
A Urbano-Ispizua
Research15 May 2003
Leukemia

Volume: 17, P: 941-959

Previous page
page 1
page 2
Next page

Search

Search articles by subject, keyword or author

Show results from

Advanced search

Quick links

Explore articles by subject
Find a job
Guide to authors
Editorial policies

Nature.com

nature.com sitemap

About Nature Portfolio

About us
Press releases
Press office
Contact us

Discover content

Journals A-Z
Articles by subject
protocols.io
Nature Index

Publishing policies

Nature portfolio policies
Open access

Author & Researcher services

Reprints & permissions
Research data
Language editing
Scientific editing
Nature Masterclasses
Research Solutions

Libraries & institutions

Librarian service & tools
Librarian portal
Open research
Recommend to library

Advertising & partnerships

Advertising
Partnerships & Services
Media kits
Branded content

Professional development

Nature Awards
Nature Careers
Nature Conferences

Regional websites

Nature Africa
Nature China
Nature India
Nature Japan
Nature Middle East

Privacy Policy
Use of cookies
Legal notice
Accessibility statement
Terms & Conditions
Your US state privacy rights

© 2025 Springer Nature Limited